Medical commercial leader with 29+ years of experience launching novel biomarkers and technology across multiple healthcare segments. Proven track record of success in fundraising and board management.
Overview
34
34
years of professional experience
Work History
Chief Executive Officer
Kiyatec, Inc.
Greenville, SC
12.2023 - Current
Managed relationships with shareholders, stakeholders, customers, and other key constituents.
Raised over $3M in funding since taking over as CEO through a convertible note round.
Reduced operational costs through removal of non-essential services, enhancing budget by $1M
2024 YTD patient tissue received increased by 103% over 2023 (through October).
Developed and introduced a cutting-edge ovarian examination panel in Q3 2024
Signed lab services agreement with South Korean automated 3D Cell Culture platform partner, MBD.
Led team that has more than doubled hospital sites in 2024 - Mayo Clinic, Ohio State University, Miami Cancer Institute, University of Nebraska, and University of Texas SW, to name a few.
Achieved College of American Pathology accreditation for the laboratory in November 2024
Presented 3D Predict Glioma update to National Cancer Guidelines in October 2024
Chief Business Officer/President
Kiyatec, Inc.
Greenville, SC
03.2023 - 11.2023
Hiring established at the board level to impact a business that lacked experienced leadership.
Created annual budgets, monitored expenses, and managed financial operations.
Cut quarterly burn rate by $1M in under 6 months.
Overhauled comprehensive commercial plan for 3D Predict Glioma.
Revamped market access team immediately upon hire and initiated 3D Predict Glioma reimbursement submission.
Created fundraising pitch deck to support fundraising efforts.
Evaluated performance metrics across departments to ensure organizational goals are met.
Senior Vice President North American Sales
LumiraDx
Waltham , MA
05.2021 - 12.2022
Headed sales team in start-up selling innovative microfluidic diagnostic tests to medical sectors
Added 5,000 instruments within 12 months
Developed relationships with prominent US distributors such as Thermo Fisher and McKesson.
Developed educational programs for over 1,000 medical sales representatives within distribution partner organizations.
Distribution partnerships added 3,602 instruments in 2,358 locations in 12 months.
Formulated strategic proposals to secure new business opportunities
Determined training objectives and monitored team performance to refine training methods and content.
Chief Commercial Officer
Lumos Diagnostics
Sarasota, FL
07.2018 - 05.2021
Spearheading Lumos MVP product FebriDx's launch in OUS market with early CE mark.
Established Lumos distribution network across Germany, Switzerland, Benelux, Iberia, United Kingdom, Greece, Turkey, Malaysia, Singapore, Canada and Australia
Developed and executed commercialization strategy for revenue growth at Lumos Diagnostics.
Conducted market development activities resulting in three peer-reviewed publications about FebriDx as a triage tool during the COVID-19 pandemic
Currently formulating and implementing USA business strategy starting with key commercial leadership hires, including VP of Sales.
Helped raise $18M to facilitate the 2021 US market entry
VICE PRESIDENT GLOBAL SALES - DIAGNOSTICS
Singulex
Alameda, CA
06.2017 - 07.2018
Created a worldwide sales and service division for Clarity System and distinct biomarkers
Launched CE marked cTnI test across European Union, United Kingdom and Nordic regions
Developed a high-caliber sales force in anticipation of FDA clearance
Directed customer service operations with integrated support from specialized scientists and engineers
VICE PRESIDENT GLOBAL SALES AND MARKETING
Astute Medical, Inc
San Diego, California
04.2011 - 07.2017
Successfully introduced and commercialized FDA-approved NephroCheck test in both EU & US markets
Led commercial efforts in product development team
Outlined go-to-market strategies in meetings with directors on a quarterly basis
Led commercial efforts in three funding rounds ($140M) presenting the NephroCheck product story to potential investors and partners.
Developed brand identity by leveraging comprehensive market research data
Expanded market reach across Germany, France, Spain, Italy, Belgium and Nordics
Designed curriculum covering disease state, product studies, and complex selling techniques
Achieved FDA approval in late 2014, opening US market access.
Established a comprehensive NephroCheck sales and implementation framework for streamlined sales team operations.
Developed value hypothesis presentation highlighting AKI cost impact and potential savings using The NephroCheck Test.
Showcased achievements with leading health systems like Tri-Star Centennial, Baycare System, Sharp System, and IU Healthcare.
VICE PRESIDENT MARKETING
Alere Medical Formally Inverness Medical
San Diego, California
08.2010 - 04.2011
Oversaw a $600 million business as the marketing leader for North America's diagnostic products.
Directed a team of 30 marketing staff committed to supporting sales objectives through effective tactical strategies
Transformed marketing department culture by establishing career paths within the organization.
Multiple product launches - Epoc Blood Analysis System, HemoSense Optimize Test Strip, and iFOB test.
Created a universal Marketing Planning process across all products.
Restructured the department into focused product segments, allowing for an overall reduction of 7.
VICE PRESIDENT OF SALES
Inverness Medical Formally Biosite - Physician Diagnostic Group
San Diego, California
11.2007 - 08.2010
Integrated Biosite, Cholestech, HemoSense, and Inverness into the Physician Diagnostic Group
Developed core initiatives including mission and vision statements, synergy strategies, territory alignment.
Physician Diagnostic Group organization consisted of over 100 employees, from sales to technical support.
Implemented a thorough reward system encouraging Account Executive to equally push all products
Launched new HemoSense InRatio 2 monitor, Salesforce.com, and Integrity Selling in 2008.
Increased total revenue contribution to IMI by $158 million
2009 growth was $46.8 million, which accounted for 29% of the total revenue contribution to IMI, amounting to $206 million.
Achieved top market share in Biosite, Cholestech, and Rapid Flu/RSV testing by end of 2009
REGIONAL SALES DIRECTOR
Biosite Corporation
San Diego, California
03.2006 - 10.2007
Enhanced Biosite market presence in hospital labs and ERs across the western region.
Oversaw team of 12 employees handling $30 million annual revenue
Accomplished seven Total Quality Improvement (TQI) initiatives in 2006.
Achieved $2.5 million in annual sales by boosting POC closes
Transformed historically low sales ranking into top three positions, with significant growth metrics
National Sales Meeting Director for 2007 "The Amazing Race" in Palm Desert California.
HOSPITAL SYSTEM EXECUTIVE
Biosite Corporation
San Diego, California
04.2005 - 03.2006
Successfully sold Biosite novel biomarkers to C-Suite executives.
Engaged with senior executives like CEO, COO, CFO and Medical Director at large hospitals
Generated robust forecast for Q1/Q2 2006 with 10 POC accounts
Collaborated with Catholic Healthcare West to enhance established contract
DIRECTOR OF MARKETING - HOSPITAL SEGMENT
Biosite Corporation
San Diego, California
08.2003 - 04.2005
Boosted annual income through new tactics in markets exceeding $150 million
Launched Triage BNP for Beckman Systems, which included a product launch binder, advertising campaign, direct mail campaign, technical white paper, and a CPR calculator.
Generated over $3 million in contract renewals through innovative placement strategies.
Targeted Hospital Executive meetings to establish company presence.
Created the Total Triage Solution selling method to impact POC growth through value selling and positioning.
EAST COAST DISTRICT SALES MANAGER
Abbott Laboratories
Bedford, Ma
12.2002 - 08.2003
Achieved $22 million in sales across three product lines including Precision PCx Glucose System, I-STAT Analyzer, and Precision Web System
Regional sales and profits exceeded targets by 102% and 108%, respectively, by end of Q2
Achieved top performance in I-STAT product line extensions
SR. PRODUCT MANAGER
Abbott Laboratories
Bedford, Ma
04.2000 - 12.2002
Developed comprehensive marketing strategies for the i-STAT point of care product line worth over $50 million annually
Developed effective marketing plans for the i-STAT product.
Realized 20% compounded growth milestone, resulting in a $60M payment to Abbott
Achieved $4.8 Million in sales during the first year of launching the i-STAT 1 Analyzer in 2001
Introduced ACT, CG4, and CG8 cartridges to market, adding over $5M in sales
Achieved unprecedented six consecutive quarters of cartridge growth for i-STAT product line
POINT OF CARE SPECIALIST
Abbott Laboratories
Bedford, Ma
07.1997 - 04.2000
Specialized in point of care sales for i-STAT Blood Gas Analyzer, Precision PCx Blood Glucose Monitor, and Precision Net Data Management System
Sold exclusively to Integrated Health Networks and hospitals with greater than 400 beds.
Delivered detailed data networking solutions across Massachusetts General and Brigham and Women's Hospitals
Led the country in Precision Net placements for 1998 and 1999.
Led the country in i-STAT analyzer sales 1999.
RETAIL ACCOUNT MANAGER
Boehringer Mannheim
Indianapolis, IN
10.1995 - 07.1997
Increased sales for the AccuCheck Blood Glucose product line in retail sector.
Managed territory worth $4.3MM in annual sales.
Coordinated, organized, and executed 60 retail promotions, totaling over $800M in incremental sales.
ACCOUNT MANAGER
Boehringer Mannheim
Indianapolis, IN
09.1993 - 10.1995
Closed Accucheck Glucose product sales across hospitals, physician offices and independent pharmacies.
Completed training in patient-focused selling technique through collaboration with Eli Lilly
TERRITORY MANAGER
American Greeting Corporation
Cleveland, Oh
10.1990 - 09.1993
Increased sales volume at store level through effective prospecting of new independent store opportunities for card departments.
Outstanding Performance Award Eastern Region 1991, Hartford District Representative of the Year 1991, Sales Representative of the Year 1992
Education
MASS COMMUNICATION
Rhode Island College
1990
Skills
Global Product Launch
Product Development
Product Branding
Ground up Organization Creation
Company Fundraising
Board Presentations/Management
Incentive Compensation Development
Sales/Implementation Process Creation
Key account development
Recruiting and hiring
Market intelligence
Profit and revenue-generating strategies
Brand-building strategies
Multidisciplinary team leadership
Strategic Partnerships
Timeline
Chief Executive Officer
Kiyatec, Inc.
12.2023 - Current
Chief Business Officer/President
Kiyatec, Inc.
03.2023 - 11.2023
Senior Vice President North American Sales
LumiraDx
05.2021 - 12.2022
Chief Commercial Officer
Lumos Diagnostics
07.2018 - 05.2021
VICE PRESIDENT GLOBAL SALES - DIAGNOSTICS
Singulex
06.2017 - 07.2018
VICE PRESIDENT GLOBAL SALES AND MARKETING
Astute Medical, Inc
04.2011 - 07.2017
VICE PRESIDENT MARKETING
Alere Medical Formally Inverness Medical
08.2010 - 04.2011
VICE PRESIDENT OF SALES
Inverness Medical Formally Biosite - Physician Diagnostic Group
11.2007 - 08.2010
REGIONAL SALES DIRECTOR
Biosite Corporation
03.2006 - 10.2007
HOSPITAL SYSTEM EXECUTIVE
Biosite Corporation
04.2005 - 03.2006
DIRECTOR OF MARKETING - HOSPITAL SEGMENT
Biosite Corporation
08.2003 - 04.2005
EAST COAST DISTRICT SALES MANAGER
Abbott Laboratories
12.2002 - 08.2003
SR. PRODUCT MANAGER
Abbott Laboratories
04.2000 - 12.2002
POINT OF CARE SPECIALIST
Abbott Laboratories
07.1997 - 04.2000
RETAIL ACCOUNT MANAGER
Boehringer Mannheim
10.1995 - 07.1997
ACCOUNT MANAGER
Boehringer Mannheim
09.1993 - 10.1995
TERRITORY MANAGER
American Greeting Corporation
10.1990 - 09.1993
MASS COMMUNICATION
Rhode Island College
Similar Profiles
Kelley TollisonKelley Tollison
Clinical Research Associate at KiyatecClinical Research Associate at Kiyatec